ivermectin aglycone (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
93
Structured Review
Santa Cruz Biotechnology
ivermectin aglycone
Ivermectin Aglycone, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivermectin+aglycone/Ivermectin+aglycone/pmc12517496-119-8-10
Average 93 stars, based on 5 article reviews
Ivermectin Aglycone, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ivermectin+aglycone/Ivermectin+aglycone/pmc12517496-119-8-10
Average 93 stars, based on 5 article reviews
ivermectin aglycone - by Bioz Stars,
2026-09
93/100 stars
Images
1) Product Images from "Analyses of emerging macrocyclic lactone resistance: Speed and signature of ivermectin and moxidectin selection and evidence of a shared genetic locus"
Article Title: Analyses of emerging macrocyclic lactone resistance: Speed and signature of ivermectin and moxidectin selection and evidence of a shared genetic locus
Journal: PLOS Pathogens
doi: 10.1371/journal.ppat.1013578
Figure Legend Snippet: Larval development assays were undertaken for all lines, at pre- and post-treatment timepoints, in the third generation of selection. (A) Control (CTL) lines had no treatment applied but sampling was time-matched with the selected lines ((B) IVM = ivermectin and (C) MOX = moxidectin). Y axis shows the proportion of the population in each well that developed to L3.
Techniques Used: Selection, Control, Sampling
Figure Legend Snippet: (A–C) Each sample from each generation is compared with the F0 parental sample and 10 kb window F st values plotted along the chromosomes (I-X). For each of the ivermectin selected (IVM) and moxidectin selected (MOX) lines, a line was plotted indicating five standard deviations above the genome-wide mean of the F3 generations (dashed and dotted respectively). CTL = control lines. Note that no sequence data was available for sample IVM1. (D) Chromosome V pairwise comparisons of third generation ivermectin and moxidectin samples to each other. Horizontal lines are five standard deviations above the mean F st value for the F3 generations – the same as in panels A-C, but with both ivermectin and moxidectin lines overlaid on each faceted plot.
Techniques Used: Genome Wide, Control, Sequencing
Figure Legend Snippet: (A–C) Ratio of nucleotide diversity in three generations (F1 to F3) of sub-therapeutic selection in comparison to F0 sample population. Key: C = control, I = ivermectin, M = moxidectin. L1 to L3 indicate biological replicate selection lines. Pi ratio = Normalised Sample θπ/ Normalised F0 θπ. Nucleotide diversity for each sample window was normalised by dividing by the genome-wide median diversity. Colour indicates the rank within the treatment group, where blue indicates a higher diversity than F0, and red a lower diversity. Note that the rank indicates the genome-wide ranking. Note that no sequence data was available for sample F1_I_L1. (D) Nucleotide diversity (θπ) of the F0 sample along Chromosome V. More negative values indicate lower diversity.
Techniques Used: Selection, Comparison, Control, Genome Wide, Sequencing
Figure Legend Snippet: (A) Ivermectin selected lines, (B) moxidectin selected lines, (C) control lines, (D) F0 sample. Note that no sequence data was available for sample F1_I_L1. More negative values (red) correlate to more rare alleles than expected for the population size, while more positive values (blue) indicate fewer rare alleles than expected and either very few alleles at all (highly conserved), or balancing selection of alleles. If the population is neutrally evolving, Tajima’s D is close to zero (mix of rare and common alleles).
Techniques Used: Control, Sequencing, Selection
Figure Legend Snippet: Negative values indicate a reduction in the reference allele frequency at that site from F0 to F3. Each point is a SNP; red points are those which are significantly different to controls following Holm’s correction of the p-values, and where the corrected p-value is < 0.001. In other words: if red, the reference allele is changing in treated lines differently to control lines, and if negative it is reducing in the treated lines. (A) ivermectin vs control lines (slope coefficient plotted for ivermectin lines), (B) moxidectin vs control lines (slope coefficient plotted for moxidectin lines), (C) selected (ivermectin and moxidectin) vs control lines (slope coefficient plotted for combined selected lines).
Techniques Used: Control
Figure Legend Snippet: PCA plots for male (A) and female (B) datasets. Genome-wide differential gene expression visualised as karyoplots (C) with i. ivermectin selected males versus control males, ii. ivermectin selected females versus control females, iii. moxidectin selected males versus control males, iv. moxidectin selected females versus control females. Upregulated genes are in yellow, downregulated genes are in blue, with adjusted P < 0.01 for significance.
Techniques Used: Genome Wide, Gene Expression, Control
Related Articles
Selection:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Control:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Sampling:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Genome Wide:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Sequencing:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Comparison:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Gene Expression:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: RNA Sequencing Assay:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Over Expression:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Quantitative RT-PCR:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Expressing:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Transformation Assay:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Recombinant:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Staining:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Plasmid Preparation:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: Software:Article Title: Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms Article Snippet: Compounds were sourced as follows: |
